PET scans for Alzheimer's rejected for Medicare pay

Share this article:
HIPAA policies, transitions to higher care levels can cause residents to feel stigmatized
HIPAA policies, transitions to higher care levels can cause residents to feel stigmatized

Earlier this year, the Department of Health and Human Services released an action plan for tackling Alzheimer's diagnostics, treatment and funding.

Now, an HHS agency has announced that Medicare will not pay for certain imaging scans used to help diagnose Alzheimer's. The apparent contradiction between strategy and execution has some provider groups upset.

The Centers for Medicare & Medicaid Services will not grant Medicare coverage for positron emission tomography scans. PET scans can detect beta-amyloid in the brain, which is a sign of Alzheimer's. 

A PET scan by itself cannot confirm a diagnosis of Alzheimer's but it can be part of a bigger battery of tests that doctors use in the diagnosis process.

CMS officials, however, declared in their Sept. 27 release that there is “insufficient evidence” that PET scans are “reasonable and necessary” for diagnosing and treating Alzheimer's.

Instead, Medicare funds may go toward Alzheimer's-related PET scans in the context of certain types of clinical trials, or when a scan can exclude Alzheimer's in narrowly defined and clinically difficult differential diagnoses, “such as AD versus frontotemporal dementia (FTD).”

Medicare will cover one PET scan per person in clinical studies that meet a long list of criteria set by federal regulators. 

Ultimately, a government panel of experts that reviewed study results and submitted comments called for more in-depth research since it could not “confidently conclude” that PET scans improve health outcomes in individuals who display signs or symptoms of Alzheimer's.

Pharmaceutical manufacturer Lilly USA LLC originally made the request for expanded Medicare coverage in July 2012. Lilly is the maker of the PET amyloid radiopharmaceutical florbetapir (Amyvid™). 


Share this article:
close

Next Article in News

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.